Open Orphan #ORPH – Major New Contract Win with Top 3 Pharma Company August 10, 2020 – Posted in: Open Orphan (ORPH), Uncategorized

Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials is pleased to announce a new contract, valued at £4m, with a top 3 global pharmaceutical company to be the sponsor of and provide a respiratory syncytial virus (RSV) human challenge study trial. This new £4m contract represents continued conversion of Open Orphan’s substantial pipeline and generation…

Open Orphan #ORPH – New hVIVO contract signed with a European Biotech Company to provide RSV human challenge study March 6, 2020 – Posted in: Open Orphan (ORPH)

6 March 2020: Open Orphan plc (ORPH) the rapidly growing CRO specialist pharmaceutical services Group which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, is pleased to announce the signing of a new contract with a European Biotech Company for the provision of a RSV human challenge study. The study is projected to deliver £3.2m in revenue all of which is expected to be recognised in…

Open Orphan #ORPH – Major New Contract Win with Top 3 Pharma Company August 10, 2020 – Posted in: Open Orphan (ORPH), Uncategorized

Open Orphan #ORPH – New hVIVO contract signed with a European Biotech Company to provide RSV human challenge study March 6, 2020 – Posted in: Open Orphan (ORPH)

Address

Contact

Social

LEGAL